Harmine and Harmaline Downregulate TCDD-Induced Cyp1a1 in the Livers and Lungs of C57BL/6 Mice
Open Access
- 20 December 2012
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-9
Abstract
We previously demonstrated thatPeganum harmalaL. extract and its main active constituents, harmine and harmaline inhibit the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated induction of the carcinogen-activating enzyme, Cyp1a1,in vitro. However, the effect of both alkaloids on Cyp1a1in vivohas not been investigated. Therefore, the aim of this study is to examine the effect of harmine and harmaline on TCDD-mediated induction of Cyp1a1 in mice livers and lungs. C57BL/6 male mice were distributed into four groups (). First group received vehicle, while the second group received TCDD (i.p.). The third and fourth groups received either harmine or harmaline (i.p.) × 3 times along with TCDD one time with the mid dose of harmine and harmaline. All mice were sacrificed after 14 h from TCDD injection, and livers and lungs were isolated. The effect of harmine and harmaline on TCDD-mediated induction of Cyp1a1 mRNA, protein, and activity levels was determined using real-time PCR, Western blot analysis, and 7-ethoxyresurofin as a substrate, respectively. Our results showed that harmine and harmaline significantly decreased the TCDD-mediated induction of Cyp1a1 in both the livers and lungs. We concluded that harmine and harmaline are promising candidate to inhibit TCDD-mediated induction of Cyp1a1 in mice hepatic and extrahepatic tissues.
Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN 250139)
- University of Alberta (RGPIN 250139)
This publication has 30 references indexed in Scilit:
- Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanismsFood and Chemical Toxicology, 2012
- Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmolToxicology Letters, 2012
- Dioxin Exposure and Cancer Risk in the Seveso Women’s Health StudyEnvironmental Health Perspectives, 2011
- Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) ReceptorToxicological Sciences, 2011
- Aryl Hydrocarbon Receptor Nuclear Translocator in Hepatocytes Is Required for Aryl Hydrocarbon Receptor–Mediated Adaptive and Toxic Responses in LiverToxicological Sciences, 2010
- Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogsCancer Letters, 2008
- CYP1A1, Cigarette Smoking, and Colon and Rectal CancerAmerican Journal of Epidemiology, 2004
- Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyreneJournal of Applied Toxicology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Role of CYP1A2 in Hepatic Sequestration of Dioxin: Studies Using CYP1A2 Knock-Out MiceBiochemical and Biophysical Research Communications, 1997